The Human Positive Cofactor 4 is a Promising Chemotherapeutic Target in Lung Adenocarcinoma

Reduced sensitivity to chemotherapeutic drugs is almost inevitable in lung adenocarcinoma patients. Thus, understanding the relevant mechanisms is urgent. Positive cofactor 4 (PC4) was at first revealed to be a coactivator of basal transcription. Previous research has shown that PC4 participates in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Tianyu, Zhang, Jingge, Fan, Xiaoqing, Long, Tan, Tao, Shaolin, Kang, Poming, Tan, Qunyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664520/
https://www.ncbi.nlm.nih.gov/pubmed/34899911
http://dx.doi.org/10.1155/2021/9958483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664520/
https://www.ncbi.nlm.nih.gov/pubmed/34899911
http://dx.doi.org/10.1155/2021/9958483

Ejemplares similares